Figure 3
From: Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
(A) Association between baseline CSF sTREM2 and tau and Aβ-PET rate of change, (B) association between baseline CSF sTREM2 and baseline tau and Aβ-PET.
